EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo

Nian E Zhou, Su Tang, Xuelin Bian, Maloy K Parai, Inna V Krieger, Armando Flores, Pradeep K Jaiswal, Radha Bam, Jeremy L Wood, Zhe Shi, Laura J Stevens, Trevor Scobey und 20 weitere

Cell Reports · 2024-11 · 43 (11) · 114929

DOI: 10.1016/j.celrep.2024.114929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-11. Verfasst von Nian E Zhou und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77840, USA. Hauptthemen laut MEDLINE: Virus Replication, SARS-CoV-2, Antiviral Agents, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus ReplicationSARS-CoV-2Antiviral AgentsCOVID-19COVID-19 Drug TreatmentAnimalsHumansMiceCricetinaeCoronavirus 3C ProteasesChlorocebus aethiopsAdministration, OralVero CellsMesocricetusCell LineProtease InhibitorsFemaleDisease Models, Animal

Stichwörter der Autor:innen

CP: MicrobiologyPaxlovidSARS-CoV-2antiviralbroad-spectrumcoronavirusemerging virusesproteasetherapeutics

Substanzen

Antiviral AgentsCoronavirus 3C Proteases3C-like proteinase, SARS-CoV-2Protease Inhibitors

Autor:innen und Institutionen

  • Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77840, USA.
  • Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Calibr-Skaggs Institute for Innovative Medicine, La Jolla, CA 92037, USA.
  • Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research
  • Japan Agency for Medical Research and Development
  • Welch Foundation
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • North Carolina General Assembly

Zitieren

APA

Zhou, N. E., Tang, S., Bian, X., Parai, M. K., Krieger, I. V., Flores, A., Jaiswal, P. K., Bam, R., Wood, J. L., Shi, Z., Stevens, L. J., Scobey, T., Diefenbacher, M. V., Moreira, F. R., Baric, T. J., Acharya, A., Shin, J., Rathi, M. M., Wolff, K. C., …, & Sacchettini, J. C. (2024). An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo. Cell Reports, 43(11), 114929. https://doi.org/10.1016/j.celrep.2024.114929

Vancouver

Zhou NE, Tang S, Bian X, Parai MK, Krieger IV, Flores A, et al. An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo. Cell Reports. 2024;43(11):114929. doi:10.1016/j.celrep.2024.114929

BibTeX
@article{Zhou2024,
  author = {Zhou, Nian E and Tang, Su and Bian, Xuelin and Parai, Maloy K and Krieger, Inna V and Flores, Armando and Jaiswal, Pradeep K and Bam, Radha and Wood, Jeremy L and Shi, Zhe and Stevens, Laura J and Scobey, Trevor and Diefenbacher, Meghan V and Moreira, Fernando R and Baric, Thomas J and Acharya, Arjun and Shin, Joonyoung and Rathi, Manish M and Wolff, Karen C and Riva, Laura and Bakowski, Malina A and McNamara, Case W and Catanzaro, Nicholas J and Graham, Rachel L and Schultz, David C and Cherry, Sara and Kawaoka, Yoshihiro and Halfmann, Peter J and Baric, Ralph S and Denison, Mark R and Sheahan, Timothy P and Sacchettini, James C},
  title = {An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {11},
  pages = {114929},
  doi = {10.1016/j.celrep.2024.114929}
}
Kostenlos starten →